IGRT in rectal cancer

Acta Oncologica

Volumn 47, Issue 7, 2008, Pages 1317-1324

  Ippolito, Edy ^a   Mertens, Ine ^b   Haustermans, Karin ^b   Gambacorta, Maria Antonietta ^a   Pasini, Danilo ^a   Valentini, Vincenzo ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; DOSIMETRY; HIGH RISK PATIENT; HUMAN; IMAGE GUIDED RADIATION THERAPY; IMAGING SYSTEM; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; RECTUM CANCER; REVIEW; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

HUMANS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 51049086621     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802256459     Document Type: Review

References (54)

1. Bernier J, Hall EJ, Giaccia A. Radiation oncology: A century of achievements. Nat Rev Cancer 2004;4:737-47.
2. Dawson LA, Jaffray DA. Advances in image-guided radiation therapy. J Clin Oncol 2007;25:938-46.
3. Ling CC, Yorke E, Fuks Z. From IMRT to IGRT: Frontierland or neverland? Radiother Oncol 2006;78:119-22.
4. Balter JM, Kessler ML. Imaging and alignment for image guided radiation therapy. J Clin Oncol 2007;25:931-7.
5. Verellen D, De Ridder M, Linthout N, Tournel K, Soete G, Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer 2007;7:949-60.
6. Xing L, Thorndyke B, Schreibmann E, Yang Y, Li TF, Kim GY, et al. Overview of image-guided radiation therapy. Med Dosim 2006;31:91-112.
7. Verellen D, De Ridder M, Storme G. A (short) history of image-guided radiotherapy. Radiother Oncol 2008;86:4-13.
8. Kapiteijn E, Marijnen CAM, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. The Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New Engl J Med 2001;345:638-46.
9. Nagtegaal ID, Marijnen CAM, Klein Kranenbarg E, Van de Velde CJ, Van Krieken JH. Circumferential margin is still an important predictor of local recurrence in rectal carcinoma: Not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002;26:350-7.
10. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40.
11. Gerard JP, Chapet O, Nemoz C, Hartweig J, Romestaing P, Coquard R, et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The Lyon R96-02 randomized trial. J Clin Oncol 2004;22:2404-9.
12. Påhlman L. Optimal management of rectal cancer - Is sphincter saving an important end-point? EJC Supplements 2005;65:365-9.
13. Heald RJ, Ryall RDH. Recurrence and survival after total mesorectal excision for rectal-cancer. Lancet 1986;1:1479-82.
14. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al. The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693-701.
15. Sebag-Montefiore D, Steele R, Quirke P, Grieve R, Khanna S, Monson J, et al. Routine short course preoperative radiotherapy or selective postoperative chemoradiotherapy for respectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. J Clin Oncol 2006;24(Suppl 18):3511. (Abstract)
16. Roels S, Duthoy W, Haustermans K, Penninckx F, Vandecaveye V, Boterberg T, et al. Definition and delineation of the CTV for rectal cancer. Int J Radiat Oncol Biol Phys 2006;65:1129-42.
17. Syk E, Torkzad R, Blomqvist L, Ljungqvist O, Glimelius B. Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer. Br J Surg 2006;93:113-9.
18. Roeder F, Treiber M, Oertel S, Dinkel J, Timke C, Funk A, et al. Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2007;67:1381-8.
19. Kim TH, Jeong SY, Choi DH, Kim DY, Jung KH, Moon SH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 2008;15:729-37.
20. Kusters M, Beets-Tan RGH, Van de Velde CJH, Rutten HJT, Marijnen CAM, Putter H, et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, with focus on the patterns of local recurrence. Ann Oncol 2008;19(Suppl 1)06.05 (Abstract).
21. Canessa CE, Badia F, Fierro S, Fiol V, Hayek G. Anatomic study of the lymph nodes of the mesorectum. Dis Colon Rectum 2001;44:1333-6.
22. Zheng YC, Zhou ZG, Li L, Lei W, Deng YL, Chen DY, et al. Distribution and patterns of lymph nodes metastases and micrometastases in the mesorectum of rectal cancer. J Surg Oncol 2007;96:213-9.
23. Mangan CE, Rubin SC, Rabin DS, Mikuta JJ. Lymphnode nomenclature in gynecologic oncology. Gynec Oncol 1986;23:222-6.
24. Takahashi T, Ueno M, Azekura K, Ohta H. Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum 2000;43(Suppl 10):S59-68.
25. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005;23:5644-50.
26. Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 2005;92:756-63.6.
27. Steup WH, Moriya Y, van de Velde CJH. Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer 2002;38:911-8.
28. Moriya Y, Sugihara K, Akasu T, Fujita S. Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 1997;21:728-32.
29. Hida J, Yasutomi M, Fujimoto K, Maruyama T, Okuno K, Shindo K. Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method. J Am Coll Surg 1997;184:475-80.
30. Arcangeli S, Valentini V, Nori SL, Fares C, Dinapoli N, Gambacorta MA. Underlying anatomy for CTV contouring and lymphatic drainage in rectal cancer radiation therapy. Rays 2003;28:331-6.
31. Hurkmans CW, Remeijer P, Lebesque JV, Mijnheer BJ. Set-up verification using portal imaging: Review of current clinical practice. Radiother Oncol 2001;58:105-20.
32. Roels S, Verstraete J, Hausterman K. Set-up verification on a belly-board device using electronic portal imaging. J Radiother Pract 2007;5:1-10.
33. Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol 2003;69:291-304.
34. Muren LP, Redpath AT, Lord H, McLaren D. Image-guided radiotherapy of bladder cancer: Bladder volume variation and its relation to margins. Radiother Oncol 2007;84:307-13.
35. Nuyttens JJ, Robertson JM, Yan D, Martinez A. The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int J Radiat Oncol Biol Phys 2002;53:497-503.
36. Tinger A, Michalski JM, Cheng A, Low DA, Zhu R, Bosch WR, et al. A critical evaluation of the planning target volume for 3D conformal radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1998;42:213-21.
37. Stroom JC, Koper PCM, Korevaaar GA, Van Os M, Janssen M, De Boer HC, et al. Internal organ motion in prostate cancer patients treated in prone and supine treatment position. Radiother Oncol 1999;51:237-48.
38. Hoogeman MS, Van Herk M, De Bois J, Muller-Timmermans P, Koper PCM, Lebesque JV. Quantification of local rectal wall displacements by virtual rectum unfolding. Radiother Oncol 2004;70:21-30.
39. Fokdal L, Honoré H, Hoyer M, Meldgaard P, Fode K, Von der Maase H. Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. Int J Radiat Oncol Biol Phys 2004;59:436-44.
40. Stasi M, Munoz F, Fiorino C, Pasquino M, Baiotto B, Marini P, Malinverni G, et al. Emptyingthe rectum before treatment delivery limits the variations of rectal dose-volume parameters during 3DCRT of prostate cancer. Radiother Oncol 2006;80:363-70.
41. Lotz HT, Pos FJ, Hulshof MCCM, Van Herk M, Lebesque JV, Duppen JC, et al. Tumor motion and deformation during external radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 2006;64:1551-8.
42. Roeske JC, Forman JD, Mesina CF, He T, Pelizzari CA, Fontenla E, et al. Evaluation of changes in the size and location of the prostate, seminal vescicles, bladder and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 1995;33:1321-9.
43. Crook JM, Raymond Y, Salhani D, Yang H, Esche B. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 1995;37:35-42.
44. Lebesque JV, Bruce AM, Kroes APG, Touw A, Shouman RT, Van Herk M. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys 1995;33:1109-19.
45. Myerson R, Drzymala R. Technical aspects of image-based treatment planning of rectal carcinoma. Semin Radiat Oncol 2003;13:433-40.
46. Gunderson LL, Russell AH, Llewellyn HJ, Doppke KP, Tepper JE. Treatment planning for colorectal cancer: Radiation and surgical techniques and value of small-bowel films. Int J Radiat Oncol Biol Phys 1985;11:1379-93.
47. Bonin SR, Lanciano RM, Corn BW, Hogan WM, Hartz VH, Hanks GE. Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy. Int J Radiat Oncol Biol Phys 1996;34:167-72.
48. Pendlebury SC, Cahill S, Crandon AJ, Bull CA. Role of bipedal lymphangiogram in radiation treatment planning for cervix cancer. Int J Radiat Oncol Biol Phys 1993;27:959-62.
49. Chao KS, Lin M. Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002;54:1147-52.
50. Borger JH, Van den Bogaard J, De Haas DFM, Braeken APBM, Murrer LHP, Houben RMA, et al. Evaluation of three different CT simulation and planning procedures for the preoperative irradiation of operable rectal cancer. Radiother Oncol 2008 (in press).
51. Guerrero Urbano MT, Henrys AJ, Adams EJ, Norman AR, Bedford JL, Harrington KJ, et al. Intensity modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys 2006;65:907-16.
52. Duthoy W, De Gersem W, Vergote K, Boterberg T, Derie C, Smeets P, et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys 2004;60:794-806.
53. De Ridder M, Tournel K, Van Nieuwenhove Y, Engels B, Hoorens A, Everaert H, et al. Phase II study of preoperative helical tomotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2008;70:728-34.
54. Janek S, Svensson R, Jonsson C, Brahme A. Development of dose delivery verification by PET imaging of photonuclear reactions following high energy photon therapy. Phys Med Biol 2006;51:5769-83.